NanO2TM — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-06-30 in 8d
ESTIMATED |
READOUT
A Study of NanO2™ Combined With Radiation and Temozolomide in Patients With Newl
Phase 2 · Glioblastoma Multiforme |
NuvOx LLC | NanO2TM |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|